Cargando…
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
BACKGROUND: Cervical dystonia (CD) can be effectively managed by a combination of botulinum neurotoxin A (BoNT-A) and conventional therapy (skeletal muscle relaxants and rehabilitative therapy), but the costs of different interventions in the UK vary. METHODS: A budget impact model was developed fro...
Autores principales: | Abogunrin, Seye, Brand, Sarah, Desai, Kamal, Dinet, Jerome, Gabriel, Sylvie, Harrower, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573201/ https://www.ncbi.nlm.nih.gov/pubmed/26392782 http://dx.doi.org/10.2147/CEOR.S86355 |
Ejemplares similares
-
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017) -
Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020) -
Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia
por: Samotus, Olivia, et al.
Publicado: (2023) -
Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
por: Abogunrin, Seye, et al.
Publicado: (2015) -
Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
por: Fasano, Alfonso, et al.
Publicado: (2020)